Boston Scientific Corp - Enterprise Value To Ebitda Ratio

Boston Scientific Corp's Fiscal Year is From January To December.

The item "Enterprise-Value-To-Ebitda-Ratio" stands at 32.55 as of 09/30/2025, the lowest value since 06/30/2024.

As of the end of Boston Scientific Corp's third quarter, the item "Enterprise Value To Ebitda Ratio" stands at 32.55. This represents a decrease of -8.43 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -7.03 percent compared to the value the year prior.
The 1 year change in percent is -7.03.
The 3 year change in percent is 23.55.

The Serie's long term average value is 30.47. It's latest available value, on 09/30/2025, is 6.80 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is +39.61%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -13.53%.